Osteosarcoma and metastasis associated bone degradation—a tale of osteoclast and malignant cell cooperativity
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Osteosarcoma and metastasis associated bone degradation—a tale of osteoclast and malignant cell cooperativity. / Nørregaard, Kirstine Sandal; Jürgensen, Henrik Jessen; Gårdsvoll, Henrik; Engelholm, Lars Henning; Behrendt, Niels; Søe, Kent.
I: International Journal of Molecular Sciences, Bind 22, Nr. 13, 6865, 2021.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Osteosarcoma and metastasis associated bone degradation—a tale of osteoclast and malignant cell cooperativity
AU - Nørregaard, Kirstine Sandal
AU - Jürgensen, Henrik Jessen
AU - Gårdsvoll, Henrik
AU - Engelholm, Lars Henning
AU - Behrendt, Niels
AU - Søe, Kent
N1 - Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021
Y1 - 2021
N2 - Cancer‐induced bone degradation is part of the pathological process associated with both primary bone cancers, such as osteosarcoma, and bone metastases originating from, e.g., breast, prostate, and colon carcinomas. Typically, this includes a cancer‐dependent hijacking of processes also occurring during physiological bone remodeling, including osteoclast‐mediated disruption of the inorganic bone component and collagenolysis. Extensive research has revealed the significance of osteoclast‐mediated bone resorption throughout the course of disease for both primary and secondary bone cancer. Nevertheless, cancer cells representing both primary bone cancer and bone metastasis have also been implicated directly in bone degradation. We will present and discuss observations on the contribution of osteoclasts and cancer cells in cancer‐associated bone degradation and reciprocal modulatory actions between these cells. The focus of this review is osteosarcoma, but we will also include relevant observations from studies of bone metastasis. Additionally, we propose a model for cancer‐associated bone degradation that involves a collaboration between osteoclasts and cancer cells and in which both cell types may directly participate in the degradation process.
AB - Cancer‐induced bone degradation is part of the pathological process associated with both primary bone cancers, such as osteosarcoma, and bone metastases originating from, e.g., breast, prostate, and colon carcinomas. Typically, this includes a cancer‐dependent hijacking of processes also occurring during physiological bone remodeling, including osteoclast‐mediated disruption of the inorganic bone component and collagenolysis. Extensive research has revealed the significance of osteoclast‐mediated bone resorption throughout the course of disease for both primary and secondary bone cancer. Nevertheless, cancer cells representing both primary bone cancer and bone metastasis have also been implicated directly in bone degradation. We will present and discuss observations on the contribution of osteoclasts and cancer cells in cancer‐associated bone degradation and reciprocal modulatory actions between these cells. The focus of this review is osteosarcoma, but we will also include relevant observations from studies of bone metastasis. Additionally, we propose a model for cancer‐associated bone degradation that involves a collaboration between osteoclasts and cancer cells and in which both cell types may directly participate in the degradation process.
KW - Bone degradation
KW - Bone metastasis
KW - Osteoclast
KW - Osteosarcoma
KW - Vicious cycle
U2 - 10.3390/ijms22136865
DO - 10.3390/ijms22136865
M3 - Journal article
C2 - 34202300
AN - SCOPUS:85108446272
VL - 22
JO - International Journal of Molecular Sciences (CD-ROM)
JF - International Journal of Molecular Sciences (CD-ROM)
SN - 1424-6783
IS - 13
M1 - 6865
ER -
ID: 275372819